In vitro Activity of a New Fourth-Generation Cephalosporin, Cefoselis, Against Clinically Important Bacterial Pathogens in China
In conclusion, cefoselis showed good activity against non-ESBL-producing E. coli, K. pneumoniae, and P. mirabilis, MSSA, and was also potent against Enterobacteriaceae, P. aeruginosa, and Streptococcus.
Source: Frontiers in Microbiology - Category: Microbiology Source Type: research
More News: Acinetobacter | China Health | Gastroenteritis | Infectious Diseases | Laboratory Medicine | Microbiology | MRSA | Staphylococcus Aureus | Study | Superbugs